Nordic Capital announces agreement to sell ArisGlobal to Dassault Systèmes, following its transformation into a scaled and AI-enabled life sciences platform

Dassault Systèmes to buy ArisGlobal for up to $2bn

Dassault Systèmes buys ArisGlobal for $1.8B to embed drug-safety AI cutting regulatory work by 30%. Life Sciences is Dassault's lagging segment (-4-12% YoY); the bet fuses virtual-twin with patient data via AI-compliance, positioning connected intelligence against world-models threatening the core.